• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧诱导因子相关差异表达与上皮性卵巢癌侵袭性的关系。

Differential expression of hypoxia-inducible factors related to the invasiveness of epithelial ovarian cancer.

机构信息

Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.

Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Sci Rep. 2021 Nov 25;11(1):22925. doi: 10.1038/s41598-021-02400-1.

DOI:10.1038/s41598-021-02400-1
PMID:34824343
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8616920/
Abstract

Ovarian cancer is the most lethal gynecological cancer, and it is frequently diagnosed at advanced stages, with recurrences after treatments. Treatment failure and resistance are due to hypoxia-inducible factors (HIFs) activated by cancer cells adapt to hypoxia. IGFBP3, which was previously identified as a growth/invasion/metastasis suppressor of ovarian cancer, plays a key role in inhibiting tumor angiogenesis. Although IGFBP3 can effectively downregulate tumor proliferation and vasculogenesis, its effects are only transient. Tumors enter a hypoxic state when they grow large and without blood vessels; then, the tumor cells activate HIFs to regulate cell metabolism, proliferation, and induce vasculogenesis to adapt to hypoxic stress. After IGFBP3 was transiently expressed in highly invasive ovarian cancer cell line and heterotransplant on mice, the xenograft tumors demonstrated a transient growth arrest with de-vascularization, causing tumor cell hypoxia. Tumor re-proliferation was associated with early HIF-1α and later HIF-2α activations. Both HIF-1α and HIF-2α were related to IGFBP3 expressions. In the down-expression of IGFBP3 in xenograft tumors and transfectants, HIF-2α was the major activated protein. This study suggests that HIF-2α presentation is crucial in the switching of epithelial ovarian cancer from dormancy to proliferation states. In highly invasive cells, the cancer hallmarks associated with aggressiveness could be activated to escape from the growth restriction state.

摘要

卵巢癌是最致命的妇科癌症,通常在晚期诊断,治疗后会复发。治疗失败和耐药性是由于癌细胞激活的缺氧诱导因子(HIFs)适应缺氧环境。IGFBP3 先前被鉴定为卵巢癌的生长/侵袭/转移抑制剂,在抑制肿瘤血管生成中起关键作用。尽管 IGFBP3 可以有效地下调肿瘤增殖和血管生成,但它的作用只是暂时的。当肿瘤生长到足够大且没有血管时,就会进入缺氧状态;然后,肿瘤细胞激活 HIFs 来调节细胞代谢、增殖,并诱导血管生成以适应缺氧应激。在高度侵袭性卵巢癌细胞系中短暂表达 IGFBP3 并在小鼠中异基因移植后,异种移植瘤表现出短暂的生长停滞和去血管化,导致肿瘤细胞缺氧。肿瘤的再增殖与早期 HIF-1α 和晚期 HIF-2α 的激活有关。HIF-1α 和 HIF-2α 均与 IGFBP3 的表达有关。在异种移植瘤和转染细胞中 IGFBP3 的低表达中,HIF-2α 是主要的激活蛋白。这项研究表明,HIF-2α 的表达在从休眠到增殖状态的上皮性卵巢癌转变中至关重要。在高度侵袭性的细胞中,与侵袭性相关的癌症特征可能被激活,以逃避生长限制状态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6089/8616920/f371caa63b9c/41598_2021_2400_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6089/8616920/4914d4ecb161/41598_2021_2400_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6089/8616920/b97e460e2173/41598_2021_2400_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6089/8616920/d908b4b3a41a/41598_2021_2400_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6089/8616920/77b27d5c27d2/41598_2021_2400_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6089/8616920/43ffe92f0e46/41598_2021_2400_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6089/8616920/fb8261e9abd1/41598_2021_2400_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6089/8616920/f371caa63b9c/41598_2021_2400_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6089/8616920/4914d4ecb161/41598_2021_2400_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6089/8616920/b97e460e2173/41598_2021_2400_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6089/8616920/d908b4b3a41a/41598_2021_2400_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6089/8616920/77b27d5c27d2/41598_2021_2400_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6089/8616920/43ffe92f0e46/41598_2021_2400_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6089/8616920/fb8261e9abd1/41598_2021_2400_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6089/8616920/f371caa63b9c/41598_2021_2400_Fig7_HTML.jpg

相似文献

1
Differential expression of hypoxia-inducible factors related to the invasiveness of epithelial ovarian cancer.缺氧诱导因子相关差异表达与上皮性卵巢癌侵袭性的关系。
Sci Rep. 2021 Nov 25;11(1):22925. doi: 10.1038/s41598-021-02400-1.
2
Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin.缺氧诱导因子-2α 直接促进 BCRP 表达并介导卵巢癌干细胞对阿霉素的耐药性。
Mol Oncol. 2019 Feb;13(2):403-421. doi: 10.1002/1878-0261.12419. Epub 2019 Jan 14.
3
Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer.缺氧诱导因子 1α 介导的 LOX 表达与上皮性卵巢癌的迁移和侵袭相关。
Int J Oncol. 2013 May;42(5):1578-88. doi: 10.3892/ijo.2013.1878. Epub 2013 Mar 29.
4
Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.慢性轻度低氧诱导的 HIF-2α 通过与 HIF-1α 的竞争与 c-MYC 相互作用诱导肝癌细胞增殖。
Cell Oncol (Dordr). 2021 Oct;44(5):1151-1166. doi: 10.1007/s13402-021-00625-w. Epub 2021 Aug 2.
5
The hypoxia-associated factor switches cells from HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion.缺氧相关因子促使细胞从 HIF-1α 依赖性信号转导切换为 HIF-2α 依赖性信号转导,促进干细胞特性、侵袭性肿瘤生长和侵袭。
Cancer Res. 2011 Jun 1;71(11):4015-27. doi: 10.1158/0008-5472.CAN-10-4142. Epub 2011 Apr 21.
6
Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.敲低缺氧诱导因子 1α(HIF-1α)促进卵巢癌细胞自噬并抑制磷脂酰肌醇 3-激酶(PI3K)/AKT/雷帕霉素靶蛋白(mTOR)信号通路。
Med Sci Monit. 2019 Jun 8;25:4250-4263. doi: 10.12659/MSM.915730.
7
HIF isoforms have divergent effects on invasion, metastasis, metabolism and formation of lipid droplets.缺氧诱导因子(HIF)亚型对侵袭、转移、代谢及脂滴形成具有不同影响。
Oncotarget. 2015 Sep 29;6(29):28104-19. doi: 10.18632/oncotarget.4612.
8
Hypoxia induced CCR7 expression via HIF-1alpha and HIF-2alpha correlates with migration and invasion in lung cancer cells.缺氧通过低氧诱导因子-1α(HIF-1α)和低氧诱导因子-2α(HIF-2α)诱导CCR7表达,这与肺癌细胞的迁移和侵袭相关。
Cancer Biol Ther. 2009 Feb;8(4):322-30. doi: 10.4161/cbt.8.4.7332. Epub 2009 Feb 3.
9
Bufalin inhibits ovarian carcinoma via targeting mTOR/HIF-α pathway.蟾毒灵通过靶向 mTOR/HIF-α 通路抑制卵巢癌。
Basic Clin Pharmacol Toxicol. 2021 Feb;128(2):224-233. doi: 10.1111/bcpt.13487. Epub 2020 Oct 2.
10
The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.缺氧细胞毒素对卵巢癌中癌症干细胞扩增的抑制作用。
Biochem Biophys Res Commun. 2015 Feb 20;457(4):706-11. doi: 10.1016/j.bbrc.2015.01.053. Epub 2015 Jan 22.

引用本文的文献

1
Hypoxia alters the response of ovarian cancer cells to the mitomycin C drug.缺氧会改变卵巢癌细胞对丝裂霉素C药物的反应。
Front Cell Dev Biol. 2025 Jun 13;13:1575134. doi: 10.3389/fcell.2025.1575134. eCollection 2025.
2
IGFBP3 modulation of tumor pathogenesis and cell signaling pathways (Review).胰岛素样生长因子结合蛋白3对肿瘤发病机制和细胞信号通路的调控(综述)
Oncol Lett. 2025 Jun 3;30(2):379. doi: 10.3892/ol.2025.15125. eCollection 2025 Aug.
3
From Defense to Disease: How the Immune System Fuels Epithelial-Mesenchymal Transition in Ovarian Cancer.

本文引用的文献

1
Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis.用贝佐蒂凡抑制肾细胞癌中的缺氧诱导因子-2α:一项1期试验及生物标志物分析
Nat Med. 2021 May;27(5):802-805. doi: 10.1038/s41591-021-01324-7. Epub 2021 Apr 22.
2
Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies.缺氧介导的卵巢癌细胞对治疗反应的降低:对化疗和免疫治疗的意义。
Int J Mol Sci. 2020 Dec 14;21(24):9492. doi: 10.3390/ijms21249492.
3
IGFBP3 inhibits angiogenesis through intracellular regulation of THBS1 expression.
从防御到疾病:免疫系统如何助力卵巢癌中的上皮-间质转化
Int J Mol Sci. 2025 Apr 24;26(9):4041. doi: 10.3390/ijms26094041.
4
A vascularized tumors-on-a-chip model for studying tumor-angiogenesis interplay, heterogeneity and drug responses.一种用于研究肿瘤-血管生成相互作用、异质性和药物反应的血管化芯片肿瘤模型。
Mater Today Bio. 2025 Apr 8;32:101741. doi: 10.1016/j.mtbio.2025.101741. eCollection 2025 Jun.
5
Multicompartmentalized Microvascularized Tumor-on-a-Chip to Study Tumor-Stroma Interactions and Drug Resistance in Ovarian Cancer.用于研究卵巢癌肿瘤-基质相互作用及耐药性的多隔室微血管化肿瘤芯片
Cell Mol Bioeng. 2024 Sep 14;17(5):345-367. doi: 10.1007/s12195-024-00817-y. eCollection 2024 Oct.
6
Redox-Regulated Iron Metabolism and Ferroptosis in Ovarian Cancer: Molecular Insights and Therapeutic Opportunities.氧化还原调节的铁代谢与卵巢癌中的铁死亡:分子见解与治疗机遇
Antioxidants (Basel). 2024 Jun 28;13(7):791. doi: 10.3390/antiox13070791.
7
The Interplay Between HIF-1α and EZH2 in Lung Cancer and Dual-Targeted Drug Therapy.HIF-1α 与 EZH2 在肺癌中的相互作用及双重靶向药物治疗。
Adv Sci (Weinh). 2024 Feb;11(7):e2303904. doi: 10.1002/advs.202303904. Epub 2023 Dec 10.
8
In vitro chemo-preventive efficacy of synthetic progestin Norethindrone in human epithelial ovarian cancer.体外合成孕激素左炔诺孕酮对人卵巢上皮性癌细胞的化学预防作用。
Med Oncol. 2023 Jun 3;40(7):195. doi: 10.1007/s12032-023-02061-2.
9
Expression characteristics and their functional role of IGFBP gene family in pan-cancer.IGFBP 基因家族在泛癌中的表达特征及其功能作用。
BMC Cancer. 2023 Apr 24;23(1):371. doi: 10.1186/s12885-023-10832-3.
10
New thoughts and findings on invasion and metastasis of pancreatic ductal adenocarcinoma (PDAC) from comparative proteomics: multi-target therapy.从比较蛋白质组学角度探讨胰腺导管腺癌(PDAC)侵袭转移的新观点和新发现:多靶点治疗。
Clin Transl Oncol. 2023 Jul;25(7):1991-1998. doi: 10.1007/s12094-023-03106-8. Epub 2023 Feb 6.
胰岛素样生长因子结合蛋白3通过细胞内调节血小板反应蛋白1的表达来抑制血管生成。
Am J Cancer Res. 2020 Jun 1;10(6):1728-1744. eCollection 2020.
4
Acute vs. Chronic vs. Cyclic Hypoxia: Their Differential Dynamics, Molecular Mechanisms, and Effects on Tumor Progression.急慢性与周期性缺氧:它们的动态差异、分子机制,以及对肿瘤进展的影响。
Biomolecules. 2019 Aug 3;9(8):339. doi: 10.3390/biom9080339.
5
Regulation Is in the Air: The Relationship between Hypoxia and Epigenetics in Cancer.调控在空气中:缺氧与癌症中的表观遗传学的关系。
Cells. 2019 Apr 1;8(4):300. doi: 10.3390/cells8040300.
6
First-line treatment of women with advanced ovarian cancer: focus on bevacizumab.晚期卵巢癌女性的一线治疗:聚焦贝伐单抗。
Onco Targets Ther. 2019 Feb 8;12:1095-1103. doi: 10.2147/OTT.S155425. eCollection 2019.
7
Reference gene validation for normalization of RT-qPCR assay associated with germination and survival of rice under hypoxic condition.用于缺氧条件下水稻发芽与存活相关的逆转录定量聚合酶链反应(RT-qPCR)检测标准化的内参基因验证
J Appl Genet. 2018 Nov;59(4):419-430. doi: 10.1007/s13353-018-0466-1. Epub 2018 Sep 20.
8
Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity.半胱氨酸使卵巢癌细胞能够适应缺氧环境并逃避卡铂的细胞毒性。
Sci Rep. 2018 Jun 22;8(1):9513. doi: 10.1038/s41598-018-27753-y.
9
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.全球癌症生存趋势监测 2000-14 年(CONCORD-3):对来自 71 个国家 322 个基于人群的登记处的 37513025 名诊断患有 18 种癌症之一的患者的个体记录进行分析。
Lancet. 2018 Mar 17;391(10125):1023-1075. doi: 10.1016/S0140-6736(17)33326-3. Epub 2018 Jan 31.
10
Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma.PT2385 治疗既往治疗的晚期透明细胞肾细胞癌患者的 I 期剂量递增试验:一种首创的缺氧诱导因子-2α拮抗剂。
J Clin Oncol. 2018 Mar 20;36(9):867-874. doi: 10.1200/JCO.2017.74.2627. Epub 2017 Dec 19.